NCT03465111View on ClinicalTrials.gov

A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 8, 2024

Study Completion Date

December 8, 2024

Conditions
Scleritis
Interventions
DRUG

ACTH (adrenocorticotropic hormone) gel

The dose of H.P. Acthar Gel is 80 Units administered subcutaneously

Trial Locations (3)

78240

RECRUITING

Foresight Studies, LLC, San Antonio

94303

RECRUITING

Byers Eye Institute, Stanford University, Palo Alto

07650

RECRUITING

Metropolitan Eye Research and Surgery Institute, Palisades Park

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

collaborator

Stanford University

OTHER

collaborator

Ocular Imaging Research and Reading Center

OTHER

collaborator

Foresight Studies, LLC

OTHER

lead

Metropolitan Eye Research & Surgery Institute

OTHER

NCT03465111 - A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis | Biotech Hunter | Biotech Hunter